...
首页> 外文期刊>FEBS Open Bio >Knockdown of lncRNA MNX1‐AS1 suppresses cell proliferation, migration, and invasion in prostate cancer
【24h】

Knockdown of lncRNA MNX1‐AS1 suppresses cell proliferation, migration, and invasion in prostate cancer

机译:抑制lncRNA MNX1-AS1抑制前列腺癌中的细胞增殖,迁移和侵袭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Altered expression of long non‐coding RNAs (lncRNAs) has been reported in many malignancies, including prostate cancer. However, the role of lncRNA MNX1‐AS1 in prostate cancer has not been reported. Here, we report that MNX1‐AS1 is expressed in prostate cancer tissues and cells and that siRNA‐mediated knockdown of MNX1‐AS1 inhibits proliferation, migration, and invasion of prostate cancer DU145 and PC3 cells. In addition, down‐regulation of MNX1‐AS1 decreased expression of proliferating cell nuclear antigen, PH‐3, N‐cadherin, and vimentin, but enhanced expression of E‐cadherin. In conclusion, this is the first report that knockdown of MNX1‐AS1 suppresses prostate cancer cell proliferation, migration, and invasion. We believe that MNX1‐AS1 may be a potential new therapeutic target for prostate cancer patients.
机译:长期非编码RNA(lncRNA)的表达在许多恶性肿瘤中都有报道,包括前列腺癌。但是,尚未报道lncRNA MNX1-AS1在前列腺癌中的作用。在这里,我们报道了MNX1-AS1在前列腺癌组织和细胞中表达,而siRNA介导的MNX1-AS1的敲低抑制了前列腺癌DU145和PC3细胞的增殖,迁移和侵袭。此外,MNX1-AS1的下调降低了增殖细胞核抗原,PH-3,N-钙黏着蛋白和波形蛋白的表达,但增强了E-钙黏着蛋白的表达。总之,这是第一个报道,敲低MNX1-AS1抑制前列腺癌细胞的增殖,迁移和侵袭。我们相信MNX1-AS1可能是前列腺癌患者的潜在新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号